Dr. Seymour hasn't been part of Saliva Diagnostics for 16 years. When he left it was trading at $2 a share. 20 years from start to present is hardly "straight to zero."
Ehrlich stepped in for one in for one year. At that point after other CEOs, not Seymour, ran it into the ground, it was too far gone to save or renew as a reverse merger for another start up.
Ehrlich then took another company, which was near bankrupt, and turned it around.